RU96124804A - QUINOLINE DERIVATIVES AS ANTAGONISTS OF NK, TAKHIKININ RECEPTOR - Google Patents
QUINOLINE DERIVATIVES AS ANTAGONISTS OF NK, TAKHIKININ RECEPTORInfo
- Publication number
- RU96124804A RU96124804A RU96124804/04A RU96124804A RU96124804A RU 96124804 A RU96124804 A RU 96124804A RU 96124804/04 A RU96124804/04 A RU 96124804/04A RU 96124804 A RU96124804 A RU 96124804A RU 96124804 A RU96124804 A RU 96124804A
- Authority
- RU
- Russia
- Prior art keywords
- carboxamide
- phenylquinoline
- benzyl
- methoxycarbonyl
- ethylbenzyl
- Prior art date
Links
- 229940093918 Quinoline gynecological antiinfectives Drugs 0.000 title 1
- 230000003042 antagnostic Effects 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 229940027991 antiseptics and disinfectants Quinoline derivatives Drugs 0.000 title 1
- 150000003248 quinolines Chemical class 0.000 title 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 47
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims 39
- 150000001875 compounds Chemical class 0.000 claims 25
- -1 cyano, carboxy Chemical group 0.000 claims 25
- 125000000217 alkyl group Chemical group 0.000 claims 16
- 239000001257 hydrogen Substances 0.000 claims 11
- 229910052739 hydrogen Inorganic materials 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 10
- 239000011780 sodium chloride Substances 0.000 claims 10
- 239000012453 solvate Substances 0.000 claims 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 206010001897 Alzheimer's disease Diseases 0.000 claims 6
- 206010010904 Convulsion Diseases 0.000 claims 6
- 206010015037 Epilepsy Diseases 0.000 claims 6
- 206010065390 Inflammatory pain Diseases 0.000 claims 6
- 206010053643 Neurodegenerative disease Diseases 0.000 claims 6
- 206010038428 Renal disease Diseases 0.000 claims 6
- 206010039085 Rhinitis allergic Diseases 0.000 claims 6
- 206010046543 Urinary incontinence Diseases 0.000 claims 6
- 201000010105 allergic rhinitis Diseases 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 6
- 230000002401 inhibitory effect Effects 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 201000004681 psoriasis Diseases 0.000 claims 6
- 201000001971 Huntington's disease Diseases 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical class 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 150000002431 hydrogen Chemical class 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 206010015943 Eye inflammation Diseases 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 235000014632 disordered eating Nutrition 0.000 claims 4
- 201000006180 eating disease Diseases 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 3
- 206010063409 Acarodermatitis Diseases 0.000 claims 3
- 206010002855 Anxiety Diseases 0.000 claims 3
- 206010057666 Anxiety disease Diseases 0.000 claims 3
- 208000006673 Asthma Diseases 0.000 claims 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 3
- 206010011224 Cough Diseases 0.000 claims 3
- 206010012438 Dermatitis atopic Diseases 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 3
- 208000009856 Lung Disease Diseases 0.000 claims 3
- 206010068773 Mechanical urticaria Diseases 0.000 claims 3
- 208000007920 Neurogenic Inflammation Diseases 0.000 claims 3
- 206010061536 Parkinson's disease Diseases 0.000 claims 3
- 208000003251 Pruritus Diseases 0.000 claims 3
- 206010061920 Psychotic disease Diseases 0.000 claims 3
- 208000002200 Respiratory Hypersensitivity Diseases 0.000 claims 3
- 208000005687 Scabies Diseases 0.000 claims 3
- 241000447727 Scabies Species 0.000 claims 3
- 210000003491 Skin Anatomy 0.000 claims 3
- 208000006641 Skin Disease Diseases 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 230000036506 anxiety Effects 0.000 claims 3
- 125000004429 atoms Chemical group 0.000 claims 3
- 201000008937 atopic dermatitis Diseases 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 claims 3
- 201000000409 dermatographia Diseases 0.000 claims 3
- 235000012631 food intake Nutrition 0.000 claims 3
- 230000037406 food intake Effects 0.000 claims 3
- 125000005842 heteroatoms Chemical group 0.000 claims 3
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims 3
- 239000002464 receptor antagonist Substances 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 125000004442 acylamino group Chemical group 0.000 claims 2
- 125000000278 alkyl amino alkyl group Chemical group 0.000 claims 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229940079593 drugs Drugs 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000001544 thienyl group Chemical group 0.000 claims 2
- FCKWIJHXSVVEMN-JOCHJYFZSA-N (2R)-2-phenyl-2-[(2-phenylquinoline-4-carbonyl)amino]acetic acid Chemical compound N([C@@H](C(=O)O)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=CC=1C1=CC=CC=C1 FCKWIJHXSVVEMN-JOCHJYFZSA-N 0.000 claims 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- ZBQUMSRXWHJZNL-UHFFFAOYSA-N 2-phenyl-N-(1-phenylcyclopentyl)quinoline-4-carboxamide Chemical compound C=1C(C=2C=CC=CC=2)=NC2=CC=CC=C2C=1C(=O)NC1(C=2C=CC=CC=2)CCCC1 ZBQUMSRXWHJZNL-UHFFFAOYSA-N 0.000 claims 1
- MXNGYQJJYRVGGJ-JOCHJYFZSA-N 2-phenyl-N-[(1R)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=CC=1C1=CC=CC=C1 MXNGYQJJYRVGGJ-JOCHJYFZSA-N 0.000 claims 1
- IEDWYQQEMKCMSQ-KRWDZBQOSA-N 2-phenyl-N-[(1S)-1-phenylethyl]quinoline-4-carboxamide Chemical compound N([C@@H](C)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=CC=1C1=CC=CC=C1 IEDWYQQEMKCMSQ-KRWDZBQOSA-N 0.000 claims 1
- SZRWBPNBQABIGN-SNYZSRNZSA-N 2-phenyl-N-[(1S)-1-phenylpropyl]-3-(2-pyrrolidin-1-ylethoxy)quinoline-4-carboxamide;hydrochloride Chemical compound Cl.N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=C1C=2C=CC=CC=2)=C1OCCN1CCCC1 SZRWBPNBQABIGN-SNYZSRNZSA-N 0.000 claims 1
- MXNGYQJJYRVGGJ-QFIPXVFZSA-N 2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=CC=1C1=CC=CC=C1 MXNGYQJJYRVGGJ-QFIPXVFZSA-N 0.000 claims 1
- AOLMGSAMTRTYEX-UHFFFAOYSA-N 2-phenylquinoline-4-carboxamide Chemical compound N=1C2=CC=CC=C2C(C(=O)N)=CC=1C1=CC=CC=C1 AOLMGSAMTRTYEX-UHFFFAOYSA-N 0.000 claims 1
- PUQJQNMVSWPSHM-FTBISJDPSA-N 3-(2-aminoethoxy)-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide;hydrochloride Chemical compound Cl.N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(OCCN)C=1C1=CC=CC=C1 PUQJQNMVSWPSHM-FTBISJDPSA-N 0.000 claims 1
- JWXOTZWCNNQOTI-JIDHJSLPSA-N 3-[(dimethylamino)methyl]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide;hydrochloride Chemical compound Cl.N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(CN(C)C)C=1C1=CC=CC=C1 JWXOTZWCNNQOTI-JIDHJSLPSA-N 0.000 claims 1
- ZDTGVVKTCUJVEM-UQIIZPHYSA-N 3-[3-(dimethylamino)propoxy]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide;hydrochloride Chemical compound Cl.N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(OCCCN(C)C)C=1C1=CC=CC=C1 ZDTGVVKTCUJVEM-UQIIZPHYSA-N 0.000 claims 1
- LHMMQMRETANOJC-QHCPKHFHSA-N 3-[[2-(dimethylamino)acetyl]amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(NC(=O)CN(C)C)C=1C1=CC=CC=C1 LHMMQMRETANOJC-QHCPKHFHSA-N 0.000 claims 1
- YXEHDPNKLSDGAG-QFIPXVFZSA-N 3-acetamido-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(NC(C)=O)C=1C1=CC=CC=C1 YXEHDPNKLSDGAG-QFIPXVFZSA-N 0.000 claims 1
- WHYVQTNGHLVEHF-FQEVSTJZSA-N 3-amino-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(N)C=1C1=CC=CC=C1 WHYVQTNGHLVEHF-FQEVSTJZSA-N 0.000 claims 1
- ZPHCLGVBXOFILS-FQEVSTJZSA-N 3-amino-5-methyl-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=C(C)C=CC=C1N=1)=C(N)C=1C1=CC=CC=C1 ZPHCLGVBXOFILS-FQEVSTJZSA-N 0.000 claims 1
- SEGYHCCGUHTJGG-FQEVSTJZSA-N 3-bromo-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(Br)C=1C1=CC=CC=C1 SEGYHCCGUHTJGG-FQEVSTJZSA-N 0.000 claims 1
- TWQGEAWDDBNDPV-FQEVSTJZSA-N 3-chloro-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(Cl)C=1C1=CC=CC=C1 TWQGEAWDDBNDPV-FQEVSTJZSA-N 0.000 claims 1
- RVDBXUCLTPUWIX-QHCPKHFHSA-N 3-ethyl-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(CC)C=1C1=CC=CC=C1 RVDBXUCLTPUWIX-QHCPKHFHSA-N 0.000 claims 1
- BIAVGWDGIJKWRM-HXUWFJFHSA-N 3-hydroxy-2-phenyl-N-[(1R)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(O)C=1C1=CC=CC=C1 BIAVGWDGIJKWRM-HXUWFJFHSA-N 0.000 claims 1
- BIAVGWDGIJKWRM-FQEVSTJZSA-N 3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(O)C=1C1=CC=CC=C1 BIAVGWDGIJKWRM-FQEVSTJZSA-N 0.000 claims 1
- DDBBEPOXFYJCCQ-NRFANRHFSA-N 3-methoxy-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(OC)C=1C1=CC=CC=C1 DDBBEPOXFYJCCQ-NRFANRHFSA-N 0.000 claims 1
- SPDOLUNKNKNWJW-NRFANRHFSA-N 3-methoxy-5-methyl-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=C(C)C=CC=C1N=1)=C(OC)C=1C1=CC=CC=C1 SPDOLUNKNKNWJW-NRFANRHFSA-N 0.000 claims 1
- MQNYRKWJSMQECI-JOCHJYFZSA-N 3-methyl-2-phenyl-N-[(1R)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(C)C=1C1=CC=CC=C1 MQNYRKWJSMQECI-JOCHJYFZSA-N 0.000 claims 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- YCWLYGNDOWWYRU-QFIPXVFZSA-N 5-methyl-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=C(C)C=CC=C1N=1)=CC=1C1=CC=CC=C1 YCWLYGNDOWWYRU-QFIPXVFZSA-N 0.000 claims 1
- GGIGGJWFPKZMNP-QFIPXVFZSA-N 6-bromo-3-methyl-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC(Br)=CC=C1N=1)=C(C)C=1C1=CC=CC=C1 GGIGGJWFPKZMNP-QFIPXVFZSA-N 0.000 claims 1
- FIKHXYSLMDUDIT-QHCPKHFHSA-N 7-methoxy-3-methyl-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=C(OC)C=C1N=1)=C(C)C=1C1=CC=CC=C1 FIKHXYSLMDUDIT-QHCPKHFHSA-N 0.000 claims 1
- YFHOVJYTSOQEDP-RPBOFIJWSA-N C1([C@H](NC(=O)N2C3=CC=CC=C3C=C3C4=CC=CC=C4CC[C@H]32)C(=O)OC)=CC=CC=C1 Chemical compound C1([C@H](NC(=O)N2C3=CC=CC=C3C=C3C4=CC=CC=C4CC[C@H]32)C(=O)OC)=CC=CC=C1 YFHOVJYTSOQEDP-RPBOFIJWSA-N 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- IMRFHKJOBUPLSP-UHFFFAOYSA-N COCl(N)O Chemical compound COCl(N)O IMRFHKJOBUPLSP-UHFFFAOYSA-N 0.000 claims 1
- 210000003169 Central Nervous System Anatomy 0.000 claims 1
- 208000008433 Motor Disorders Diseases 0.000 claims 1
- UEKHCAVJPIOMIP-BVZFJXPGSA-N N([C@@H]([C@@H](O)C)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(C)C=1C1=CC=CC=C1 Chemical compound N([C@@H]([C@@H](O)C)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(C)C=1C1=CC=CC=C1 UEKHCAVJPIOMIP-BVZFJXPGSA-N 0.000 claims 1
- OVBJWAADALGYKQ-VWLOTQADSA-N N-[(1R)-2-(dimethylamino)-1-phenylethyl]-2-phenylquinoline-4-carboxamide Chemical compound N([C@@H](CN(C)C)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=CC=1C1=CC=CC=C1 OVBJWAADALGYKQ-VWLOTQADSA-N 0.000 claims 1
- WAYHLMCBGBNUES-QHCPKHFHSA-N N-[(1R)-2-amino-1-phenylethyl]-2-phenylquinoline-4-carboxamide Chemical compound N([C@@H](CN)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=CC=1C1=CC=CC=C1 WAYHLMCBGBNUES-QHCPKHFHSA-N 0.000 claims 1
- GKGPUCZXROZVOR-UHFFFAOYSA-N N-benzhydryl-2-phenylquinoline-4-carboxamide Chemical compound C=1C(C=2C=CC=CC=2)=NC2=CC=CC=C2C=1C(=O)NC(C=1C=CC=CC=1)C1=CC=CC=C1 GKGPUCZXROZVOR-UHFFFAOYSA-N 0.000 claims 1
- LQJFMHRUCPOOFI-UHFFFAOYSA-N N1=CC=C(C2=CC=CC=C12)C(=O)NC1=CC(=CC=C1)Cl Chemical compound N1=CC=C(C2=CC=CC=C12)C(=O)NC1=CC(=CC=C1)Cl LQJFMHRUCPOOFI-UHFFFAOYSA-N 0.000 claims 1
- FPYHJHQPCDCTPO-XDHUDOTRSA-N O[C@@H](C)[C@@H](C1=CC=CC=C1)NC(=O)C1=CC(=NC2=CC=CC=C12)C1=CC=CC=C1 Chemical compound O[C@@H](C)[C@@H](C1=CC=CC=C1)NC(=O)C1=CC(=NC2=CC=CC=C12)C1=CC=CC=C1 FPYHJHQPCDCTPO-XDHUDOTRSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000004945 acylaminoalkyl group Chemical group 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims 1
- 125000006620 amino-(C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000002431 aminoalkoxy group Chemical group 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- 125000005518 carboxamido group Chemical group 0.000 claims 1
- 125000003678 cyclohexadienyl group Chemical group C1(=CC=CCC1)* 0.000 claims 1
- 125000002474 dimethylaminoethoxy group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 claims 1
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 235000005686 eating Nutrition 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 238000005755 formation reaction Methods 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 1
- FYPIRCNELOFQIX-GNAFDRTKSA-N methyl (2R)-2-(4-hydroxyphenyl)-2-[(2-phenylquinoline-4-carbonyl)amino]acetate;hydrochloride Chemical compound Cl.N([C@@H](C(=O)OC)C=1C=CC(O)=CC=1)C(=O)C(C1=CC=CC=C1N=1)=CC=1C1=CC=CC=C1 FYPIRCNELOFQIX-GNAFDRTKSA-N 0.000 claims 1
- QTLPNFZRBVSFGU-XMMPIXPASA-N methyl (2R)-2-(4-methoxyphenyl)-2-[(2-phenylquinoline-4-carbonyl)amino]acetate Chemical compound N([C@@H](C(=O)OC)C=1C=CC(OC)=CC=1)C(=O)C(C1=CC=CC=C1N=1)=CC=1C1=CC=CC=C1 QTLPNFZRBVSFGU-XMMPIXPASA-N 0.000 claims 1
- FELWDLOKQHBTSX-JOCHJYFZSA-N methyl (2R)-2-[(3-hydroxy-2-phenylquinoline-4-carbonyl)amino]-2-phenylacetate Chemical compound N([C@@H](C(=O)OC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(O)C=1C1=CC=CC=C1 FELWDLOKQHBTSX-JOCHJYFZSA-N 0.000 claims 1
- IUMQXQJZIHWLIN-HSZRJFAPSA-N methyl (2R)-2-phenyl-2-[(2-phenylquinoline-4-carbonyl)amino]acetate Chemical compound N([C@@H](C(=O)OC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=CC=1C1=CC=CC=C1 IUMQXQJZIHWLIN-HSZRJFAPSA-N 0.000 claims 1
- IUMQXQJZIHWLIN-QHCPKHFHSA-N methyl (2S)-2-phenyl-2-[(2-phenylquinoline-4-carbonyl)amino]acetate Chemical compound N([C@H](C(=O)OC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=CC=1C1=CC=CC=C1 IUMQXQJZIHWLIN-QHCPKHFHSA-N 0.000 claims 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000005544 phthalimido group Chemical group 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- HPQRQAOVNXWEEQ-UHFFFAOYSA-N quinoline-8-carboxamide Chemical compound C1=CN=C2C(C(=O)N)=CC=CC2=C1 HPQRQAOVNXWEEQ-UHFFFAOYSA-N 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Claims (1)
в которой Ar представляет необязательно замещенную фенильную, нафтильную или C5-7 циклоалкдиенильную группу или необязательно замещенную одинарную или сконденсированную кольцевую гетероциклическую группу, имеющую ароматический характер, содержащую от 5 до 12 кольцевых атомов и включающую до четырех гетеро-атомов в кольце или каждом кольце, выбранных из S,O,N;
R представляет линейный или разветвленный C1-8 алкил, C3-7 циклоалкилалкил, необязательно замещенный фенил или фенил C1-6 алкил, необязательно замещенное пятичленное гетероароматическое кольцо, включающее до четырех гетеро-атомов, выбранных из O и N, гидрокси C1-6 алкил, амино C1-6 алкил, C1-6 алкиламиноалкил, ди C1-6 алкиламиноалкил, C1-6ациламиноалкил, C1-6 алкоксиалкил, C1-6 алкилкарбонил, карбокси, C1-6 алкоксикарбонил, C1-6 алкоксикарбонил- C1-6 алкил, аминокарбонил, C1-6 алкиламинокарбонил, ди C1-6 алкиламинокарбонил, галоид C1-6 алкил; или представляет группу - (СН2)р-, когда он циклизован с Ar, где p представляет 2 или 3.1. The compound, its solvate or salt of formula (I)
in which Ar represents an optionally substituted phenyl, naphthyl or C 5-7 cycloalkenyl group or an optionally substituted single or condensed ring heterocyclic group having an aromatic character containing from 5 to 12 ring atoms and including up to four hetero atoms in the ring or each ring, selected from S, O, N;
R represents a linear or branched C 1-8 alkyl, C 3-7 cycloalkylalkyl, optionally substituted phenyl or phenyl C 1-6 alkyl, optionally substituted five-membered heteroaromatic ring containing up to four hetero atoms selected from O and N, hydroxy C 1 -6 alkyl, amino C 1-6 alkyl, C 1-6 alkylaminoalkyl, di C 1-6 alkylaminoalkyl, C 1-6 acylaminoalkyl, C 1-6 alkoxyalkyl, C 1-6 alkylcarbonyl, carboxy, C 1-6 alkoxycarbonyl, C 1-6 alkoxycarbonyl-C 1-6 alkyl, aminocarbonyl, C 1-6 alkylaminocarbonyl, di C 1-6 alkylaminocarbonyl, halogen C 1-6 alkyl; or represents a group - (CH 2 ) p - when it is cyclized with Ar, where p is 2 or 3.
в которой V и V1 представляют водород или кислород, и u представляет 0, 1 или 2; -0(СН2)s-OW2, в которой s представляет 2, 3 или 4, и W представляет водород или C1-6 алкил; гидроксиалкил, аминоалкил, моно- или ди-алкиламиноалкил, ациламино, алкилсульфониламино, аминоациламино, моно- или ди-алкиламиноациламино; причем в хинолиновом ядре присутствует до четырех R3 заместителей; или R4 представляет группу - (СН2)t, когда он циклизован с R5 в виде арила, в которой t представляет 1, 2 или 3;
R5 представляет линейный или разветвленный C1-6 алкил, C3-7 циклоалкил, C4-7циклоалкилалкил, необязательно замещенный арил или необязательно замещенную одинарную или сконденсированную кольцевую гетероциклическую группу, имеющую ароматический характер, содержащую от 5 до 12 кольцевых атомов и включающую до четырех гетеро-атомов в кольце или в каждом кольце, выбранных из S, O, N;
Х представляет O, S или NC≡N
2. Соединение по п.1, в котором Ar представляет фенил, необязательно замещенный C1-6 алкилом или галогеном; тиенильную или C5-7 циклоалкдиенильную группу.R 3 and R 4 , which may be the same or different, are independently hydrogen, C 1-6 linear or branched alkyl, C 2-6 alkenyl, aryl, C 1-6 alkoxy, hydroxy, halogen, nitro, cyano, carboxy, carboxamido, sulfonamido, C 1-6 alkoxycarbonyl, trifluoromethyl, acyloxy, phthalimido, amino, mono- or di-C 1-6 alkylamino, —O (CH 2 ) r —NT 2 , in which r represents 2, 3 or 4, and T represents hydrogen or C 1-6 alkyl, or it forms a group with neighboring nitrogen
in which V and V 1 represent hydrogen or oxygen, and u represents 0, 1 or 2; -0 (CH 2 ) s -OW 2 , in which s represents 2, 3 or 4, and W represents hydrogen or C 1-6 alkyl; hydroxyalkyl, aminoalkyl, mono- or di-alkylaminoalkyl, acylamino, alkylsulfonylamino, aminoacylamino, mono- or di-alkylaminoacylamino; moreover, up to four R 3 substituents are present in the quinoline core; or R 4 represents a group - (CH 2 ) t , when it is cyclized with R 5 in the form of aryl, in which t represents 1, 2 or 3;
R 5 represents a linear or branched C 1-6 alkyl, C 3-7 cycloalkyl, C 4-7 cycloalkylalkyl, optionally substituted aryl or an optionally substituted single or condensed ring heterocyclic group, having an aromatic character, containing from 5 to 12 ring atoms and including up to four hetero atoms in the ring or in each ring selected from S, O, N;
X represents O, S or NC≡N
2. The compound according to claim 1, wherein Ar is phenyl, optionally substituted with C 1-6 alkyl or halogen; thienyl or C 5-7 cycloalkenyl group.
R представляет метил, этил, н-пропил, -COOMe или -СОМе;
R1 и R2 каждый представляет водород или метил;
R 3 представляет водород, метокси или гидрокси;
R4 представляет водород, метил, этил, метокси, гидрокси, амино, хлор, бром, диметиламиноэтокси, 2-(1-фталоил) этокси, аминоэтокси, 2-(1-пирролидинил) этокси, диметиламинопропокси, диметиламиноацетиламино, ацетиламино или диметиламинометил;
R5 представляет фенил, 2-тиенил, 2-фурил, 2-пиррил, 2-тиазолил или 3-тиенил;
Х представляет кислород.8. The compound of formula (I) according to claim 1, or its salt or solvate, in which Ar is phenyl, 2-chlorophenyl, 2-thienyl or cyclohexadienyl;
R is methyl, ethyl, n-propyl, —COOMe or —COMe;
R 1 and R 2 each represents hydrogen or methyl;
R 3 represents hydrogen, methoxy or hydroxy;
R 4 represents hydrogen, methyl, ethyl, methoxy, hydroxy, amino, chlorine, bromine, dimethylaminoethoxy, 2- (1-phthaloyl) ethoxy, aminoethoxy, 2- (1-pyrrolidinyl) ethoxy, dimethylaminopropoxy, dimethylaminoacetylamino, acetylamino or dimethylaminophenoxy,
R 5 is phenyl, 2-thienyl, 2-furyl, 2-pyrryl, 2-thiazolyl, or 3-thienyl;
X represents oxygen.
в которой R, R2, R3 и R4 имеют значения, определенные для формулы (I) в любом из пп. 1-7, и Y и Z, которые могут быть одинаковыми или различными, каждый представляет Ar, как он определен для формулы (I) в п.1 или 2.9. The compound according to any one of claims 1 to 7, or its salt, or MES, having the formula (Ia)
in which R, R 2 , R 3 and R 4 have the meanings defined for formula (I) in any of paragraphs. 1-7, and Y and Z, which may be the same or different, each represents Ar, as defined for formula (I) in claim 1 or 2.
в которой R, R2, R3 и R4, Y и Z имеют значения, определенные в п.9.10. The compound according to claim 9, (Ib)
in which R, R 2 , R 3 and R 4 , Y and Z have the meanings given in 9.
(R,S)-N-(α- метилбензил)-2-фенилхинолин-4-карбоксамида,
(+)-(S)-N-(α- метилбензил)-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-[α- метилбензил)-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α-(метоксикарбонил) бензил]-2-фенилхинолин-4-карбоксамида,
(+)-(S)-N-[α-(метоксикарбонил) бензил]-2-фенилхинолин-4-карбоксамида,
(-)-(R)-N-[α-(метоксикарбонил) бензил]-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α-(метоксикарбонил) бензил] -7-метокси-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α-(метоксикарбонил) бензил] -7-гидрокси-2-фенилхинолин-4-карбоксамида,
хлоргидрата (R, S)-N-[α-(карбокси) бензил]-7-метокси-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α-(метиламинокарбонил) бензил]-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α-(метоксикарбонил) бензил]-2-(2-тиенил)хинолин-4-карбоксамида,
(R,S)-N-[α-(метоксикарбонил) бензил]-2-(2-фурил)хинолин-4-карбоксамида,
(R, S)-N-[α-(метоксикарбонил) бензил] -2-(4-пиридил)хинолин-4-карбоксамида,
(R, S)-N-[α-(метоксикарбонил)-2-тиенилметил] -2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α-(метоксикарбонил) бензил]-2-фенилхинолин-4-карбоксамида,
(-)-(R)-N-[α-(метоксикарбонил)-1,4-циклогексадиенилметил] -2-фенилхинолин-4-карбоксамида,
индивидуального диастереомера (R,S)-N-[α-(1-гидроксиэтил) бензил]-2-фенилхинолин-4-карбоксамида,
(R,S)-N-(α-этилбензил)-3-метокси-2-фенилхинолин-4-карбоксамида,
(R,S)-N-(α-этилбензил)-3-н-бутил-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α-(метоксикарбонилметил) бензил] бензо-1,3-циклогептадиено[1,2-b] хинолин-8-карбоксамида,
(R,S)-N-(α- этилбензил)-3-гексил-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N- этилбензил)-3-метил-2-фенилхинолин-4-карбоксамида,
(+)-(R)-N-(α- этилбензил)-3-метил-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α-(метоксикарбонил) бензил]-2-(2-метоксифенил) хинолин-4-карбоксамида,
(R,S)-N-(α- этилбензил)-3-фенил-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил] -2-(2-фторфенил) хинолин-4-карбоксамида,
(R,S)-N-[α- (гидроксиметил) бензил]-2-фенилхинолин-4-карбоксамида,
(R,S)-N-(α- этилбензил)-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-3-метил-фенилхинолин-4-карбоксамида,
(R,S)-N-(α- этилбензил)-3-метил-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-7-хлор-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-6-метил-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (метоксиметил) бензил]-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-6-хлор-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-3-этил-2-фенилхинолин-4-карбоксамида,
(R,S)-N-(α- н-пропилбензил)-2-фенилхинолин-4-карбоксамида,
(R,S)-N-(α- этилбензил)-3-этил-2-фенилхинолин-4-карбоксамида,
(R,S)-N-(α- этилбензил)-3-фталимидо-2-фенилхинолин-4-карбоксамида,
(R,S)-N-(α- этилбензил)-3-н-пропил-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)-6-бром-3-метил-2-(4-бромфенил) хинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)-6-бром-3-метил-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-6-метокси-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-2-(2-бензофурил) хинолин-4-карбоксамида,
(R,S)-N-[(1,2-дифенил)этил]2-фенилхинолин-4-карбоксамида,
(R,S)-N-(α- трифторметилбензил)-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)-3-метокси-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)-3-этил-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (этил)-4-хлорбензил]-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-N-метил-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-2-(3-тиенил) хинолин4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-5,6-дигидробензо[a]-акридин-7-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-2-(2-пиррил) хинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-2-(2-тиазолил) хинолин-4-карбоксамида,
(R,S)-N-(1-индалин)2-фенилхинолин-4-карбоксамида,
(R,S)-N-(α- н-бутилбензил)-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (метоксикарбонил) бензил]-2-(4-метилфенил) хинолин-4-карбоксамида,
(R,S)-N-(α- гептилбензил)-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (метоксикарбонил) бензил]-2-(2-метилфенил) хинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-2-(4-метоксифенил) хинолин-4-карбоксамида,
N-(1-фенилциклопентил)-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (метоксикарбонил) бензил]-2-(4-гидроксифенил) хинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-2-(3,4-метилендиоксифенил) хинолин-4-карбоксамида,
N-(α,α- диметилбензил)-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (этил)-4-метилбензил]-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-2-(3-пиррил) хинолин-4-карбоксамида,
(R,S)-N-[α- (метоксикарбонил) бензил]-2-(3,4-дихлорфенил) хинолин-4-карбоксамида,
(-)-(R)-N-[α- (аминометил) бензил]-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)-3-амино-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)-3-хлор-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)3-бром-2-фенилхинолин-4-карбоксамида,
(R,S)-N-(α- изо - пропилбензил)-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)-2-фенилхинолин-4-карбоксамида,
(+)-(R)-N-(α- этилбензил)-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-6-фтор-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-2-циклогексилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-2(3-хлорфенил) хинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-2-(2-хлорфенил) хинолин-4-карбоксамида,
(R,S)-N-(α- этилбензил)-3-гидрокси-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-8-ацетилокси-2-фенилхинолин-4-карбоксамида,
(R, S)-N- (метоксикарбонил) бензил]-8-гидрокси-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил]-2-(2,4-дихлорфенил) хинолин-4-карбоксамида,
хлоргидрата (-)-(R)-N-[α- (метоксикарбонил)4-гидроксибензил]-2-фенилхинолин-4-карбоксамида,
N-дифенилметил-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)-3-гидрокси-2-фенилхинолин-4-карбоксамида,
(+)-(R)-N-(α- этилбензил)-3-гидрокси-2-фенилхинолин-4-карбоксамида,
(-)-(R)-N-[α- (метоксикарбонил) бензил] -3-гидрокси-2-фенилхинолин-4-карбоксамида,
(-)-(R)-N-[α- (диметиламинометил) бензил]-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (диметиламинометил) бензил]-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (аминокарбонил) бензил]-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (1-пирролидинилкарбонил) бензил]-2-фенилхинолин-4-карбоксамида,
(-)-(R)-N-[α-(карбокси) бензил]-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метоксикарбонил) бензил] -2-(4-хлорфенил) хинолин-4-карбоксамида,
(R)-N-[α- (метоксикарбонил)-4-метоксибензил] -2-фенилхинолин-4-карбоксамида,
хлоргидрата (R,S)-N-[α- (метоксикарбонил) -α- (метил) бензил]-N-метил-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (метилкарбонил) бензил]-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (2-гидроксиэтил) бензил]-2-фенилхинолин-4-карбоксамида,
хлоргидрата (-)-(S)-N-(α- этилбензил)-3-(2-метиламиноэтокси)-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)-3-ацетиламино-2-фенилхинолин-4-карбоксамида,
хлоргидрата (-)-(S)-N-(α- этилбензил)-3-(3-диметиламинопропокси)-2-фенилхинолин-4-карбоксамида,
хлоргидрата (-)-(S)-N-(α- этилбензил)-3-[2-(1-фталоил) этокси] -2-фенилхинолин-4-карбоксамида,
хлогидрата (-)-(S)-N-(α- этилбензил)-3-(2-аминоэтокси)-2-фенилхинолин-4-карбоксамида,
хлоргидрата (+)-(S)-N-(α- этилбензил)-3-[2-(1-пирролидинил) этокси]-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)-3-(диметиламиноацетиламино)-2-фенилхинолин-4-карбоксамида,
N-(α,α- диметилбензил)-3-гидрокси-2-фенилхинолин-4-карбоксамида,
N-(α,α- диметилбензил)-3-амино-2-фенилхинолин-4-карбоксамида,
(-)-(S)-N-(α- этилбензил)-5-метил-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (1-гидроксиэтил) бензил]-3-метил-2-фенилхинолин-4-карбоксамида,
(R, S)-N-[α- (метилкарбонил) бензил]-3-метил-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (этил)-4-пиридилметил]-2-фенилхинолин-4-карбоксамида,
(R,S)-N-[α- (этил)-2-тиенилметил]-2-фенилхинолин-4-карбоксамида,
хлоргидрата (+)-(S)-N-(α- этилбензил)-3-диметиламинометил-2-фенилхинолин-4-карбоксамида,
(S)-N-(α- этилбензил)-3-метил-7-метокси-2-фенилхинолин-4-карбоксамида,
(S)-N-(α- этилбензил)-3-амино-5-метил-2-фенилхинолин-4-карбоксамида,
(S)-N-(α- этилбензил)-3-метокси-5-метил-2-фенилхинолин-4-карбоксамида.11. The compound according to claim 1, selected from the group consisting of:
(R, S) -N- (α-methylbenzyl) -2-phenylquinoline-4-carboxamide,
(+) - (S) -N- (α-methylbenzyl) -2-phenylquinoline-4-carboxamide,
(-) - (S) -N- [α-methylbenzyl) -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2-phenylquinoline-4-carboxamide,
(+) - (S) -N- [α- (methoxycarbonyl) benzyl] -2-phenylquinoline-4-carboxamide,
(-) - (R) -N- [α- (methoxycarbonyl) benzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -7-methoxy-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -7-hydroxy-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (carboxy) benzyl] -7-methoxy-2-phenylquinoline-4-carboxamide hydrochloride,
(R, S) -N- [α- (methylaminocarbonyl) benzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (2-thienyl) quinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (2-furyl) quinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (4-pyridyl) quinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) -2-thienylmethyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2-phenylquinoline-4-carboxamide,
(-) - (R) -N- [α- (methoxycarbonyl) -1,4-cyclohexadienylmethyl] -2-phenylquinoline-4-carboxamide,
individual diastereomer (R, S) -N- [α- (1-hydroxyethyl) benzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- (α-ethylbenzyl) -3-methoxy-2-phenylquinoline-4-carboxamide,
(R, S) -N- (α-ethylbenzyl) -3-n-butyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonylmethyl) benzyl] benzo-1,3-cycloheptadieno [1,2-b] quinoline-8-carboxamide,
(R, S) -N- (α-ethylbenzyl) -3-hexyl-2-phenylquinoline-4-carboxamide,
(-) - (S) -N- ethylbenzyl) -3-methyl-2-phenylquinoline-4-carboxamide,
(+) - (R) -N- (α-ethylbenzyl) -3-methyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (2-methoxyphenyl) quinoline-4-carboxamide,
(R, S) -N- (α-ethylbenzyl) -3-phenyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (2-fluorophenyl) quinoline-4-carboxamide,
(R, S) -N- [α- (hydroxymethyl) benzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- (α-ethylbenzyl) -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -3-methyl-phenylquinoline-4-carboxamide,
(R, S) -N- (α-ethylbenzyl) -3-methyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -7-chloro-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -6-methyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxymethyl) benzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -6-chloro-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -3-ethyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- (α-n-propylbenzyl) -2-phenylquinoline-4-carboxamide,
(R, S) -N- (α-ethylbenzyl) -3-ethyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- (α-ethylbenzyl) -3-phthalimido-2-phenylquinoline-4-carboxamide,
(R, S) -N- (α-ethylbenzyl) -3-n-propyl-2-phenylquinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) -6-bromo-3-methyl-2- (4-bromophenyl) quinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) -6-bromo-3-methyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -6-methoxy-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (2-benzofuryl) quinoline-4-carboxamide,
(R, S) -N - [(1,2-diphenyl) ethyl] 2-phenylquinoline-4-carboxamide,
(R, S) -N- (α-trifluoromethylbenzyl) -2-phenylquinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) -3-methoxy-2-phenylquinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) -3-ethyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (ethyl) -4-chlorobenzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -N-methyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (3-thienyl) quinoline4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -5,6-dihydrobenzo [a] -acridine-7-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (2-pyrryl) quinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (2-thiazolyl) quinoline-4-carboxamide,
(R, S) -N- (1-indaline) 2-phenylquinoline-4-carboxamide,
(R, S) -N- (α-n-butylbenzyl) -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (4-methylphenyl) quinoline-4-carboxamide,
(R, S) -N- (α-heptylbenzyl) -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (2-methylphenyl) quinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (4-methoxyphenyl) quinoline-4-carboxamide,
N- (1-phenylcyclopentyl) -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (4-hydroxyphenyl) quinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (3,4-methylenedioxyphenyl) quinoline-4-carboxamide,
N- (α, α-dimethylbenzyl) -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (ethyl) -4-methylbenzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (3-pyrryl) quinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (3,4-dichlorophenyl) quinoline-4-carboxamide,
(-) - (R) -N- [α- (aminomethyl) benzyl] -2-phenylquinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) -3-amino-2-phenylquinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) -3-chloro-2-phenylquinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) 3-bromo-2-phenylquinoline-4-carboxamide,
(R, S) -N- (α-iso-propylbenzyl) -2-phenylquinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) -2-phenylquinoline-4-carboxamide,
(+) - (R) -N- (α-ethylbenzyl) -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -6-fluoro-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2-cyclohexylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2 (3-chlorophenyl) quinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (2-chlorophenyl) quinoline-4-carboxamide,
(R, S) -N- (α-ethylbenzyl) -3-hydroxy-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -8-acetyloxy-2-phenylquinoline-4-carboxamide,
(R, S) -N- (methoxycarbonyl) benzyl] -8-hydroxy-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (2,4-dichlorophenyl) quinoline-4-carboxamide,
(-) - (R) -N- [α- (methoxycarbonyl) 4-hydroxybenzyl] -2-phenylquinoline-4-carboxamide hydrochloride,
N-diphenylmethyl-2-phenylquinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) -3-hydroxy-2-phenylquinoline-4-carboxamide,
(+) - (R) -N- (α-ethylbenzyl) -3-hydroxy-2-phenylquinoline-4-carboxamide,
(-) - (R) -N- [α- (methoxycarbonyl) benzyl] -3-hydroxy-2-phenylquinoline-4-carboxamide,
(-) - (R) -N- [α- (dimethylaminomethyl) benzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (dimethylaminomethyl) benzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (aminocarbonyl) benzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (1-pyrrolidinylcarbonyl) benzyl] -2-phenylquinoline-4-carboxamide,
(-) - (R) -N- [α- (carboxy) benzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) benzyl] -2- (4-chlorophenyl) quinoline-4-carboxamide,
(R) -N- [α- (methoxycarbonyl) -4-methoxybenzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methoxycarbonyl) -α- (methyl) benzyl] -N-methyl-2-phenylquinoline-4-carboxamide hydrochloride,
(R, S) -N- [α- (methylcarbonyl) benzyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (2-hydroxyethyl) benzyl] -2-phenylquinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) -3- (2-methylaminoethoxy) -2-phenylquinoline-4-carboxamide hydrochloride,
(-) - (S) -N- (α-ethylbenzyl) -3-acetylamino-2-phenylquinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) -3- (3-dimethylaminopropoxy) -2-phenylquinoline-4-carboxamide hydrochloride,
(-) - (S) -N- (α-ethylbenzyl) -3- [2- (1-phthaloyl) ethoxy] -2-phenylquinoline-4-carboxamide hydrochloride,
(-) - (S) -N- (α-ethylbenzyl) -3- (2-aminoethoxy) -2-phenylquinoline-4-carboxamide hydrochloride,
(+) - (S) -N- (α-ethylbenzyl) -3- [2- (1-pyrrolidinyl) ethoxy] -2-phenylquinoline-4-carboxamide hydrochloride,
(-) - (S) -N- (α-ethylbenzyl) -3- (dimethylaminoacetylamino) -2-phenylquinoline-4-carboxamide,
N- (α, α-dimethylbenzyl) -3-hydroxy-2-phenylquinoline-4-carboxamide,
N- (α, α-dimethylbenzyl) -3-amino-2-phenylquinoline-4-carboxamide,
(-) - (S) -N- (α-ethylbenzyl) -5-methyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (1-hydroxyethyl) benzyl] -3-methyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (methylcarbonyl) benzyl] -3-methyl-2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (ethyl) -4-pyridylmethyl] -2-phenylquinoline-4-carboxamide,
(R, S) -N- [α- (ethyl) -2-thienylmethyl] -2-phenylquinoline-4-carboxamide,
(+) - (S) -N- (α-ethylbenzyl) -3-dimethylaminomethyl-2-phenylquinoline-4-carboxamide hydrochloride,
(S) -N- (α-ethylbenzyl) -3-methyl-7-methoxy-2-phenylquinoline-4-carboxamide,
(S) -N- (α-ethylbenzyl) -3-amino-5-methyl-2-phenylquinoline-4-carboxamide,
(S) -N- (α-ethylbenzyl) -3-methoxy-5-methyl-2-phenylquinoline-4-carboxamide.
в которой R', R'1, R'2 и Ar' имеют значения R, R1, R2 и Ar, определенные для формулы (I), или представляют группу или атом, превращаемые в R, R1, R2 и Ar, с соединением формулы (II)
или его активным производным, в которой R'3, R'4, R'5 и X' имеют значения R3, R4, R5 и Х, определенные для формулы (I),
или представляют группы, превращаемые в R3, R4, R5 и Х, с получением соединения формулы (Ic)
и после этого необязательно осуществляют одну или более из следующих стадий: (а) когда R', R'1 - R'5, Ar' и X' являются иными, чем R, R1 - R5, Ar и Х, превращение любого из R', R'1 - R'5, Ar' и X' в R, R1 - R5, Ar и X с получением соединения формулы (I): (b) когда R', R'1 - R'5, Ar' и X' представляют R, R1 - R5, Ar и Х, превращение любого одного из R, R1 - R5, Ar и Х в иной R, R1 - R5, Ar и Х с получением соединения формулы (I): (с) образование соли и/или сольвата полученного соединения формулы (Ic).13. The method of obtaining the compounds of formula (I), as defined in any of paragraphs. 1-12, or MES or salt, which includes the reaction of compounds of formula III
in which R ′, R ′ 1 , R ′ 2 and Ar ′ have the meanings R, R 1 , R 2 and Ar defined for formula (I), or represent a group or an atom convertible into R, R 1 , R 2 and Ar, with a compound of formula (II)
or its active derivative, in which R ′ 3 , R ′ 4 , R ′ 5 and X ′ have the meanings R 3 , R 4 , R 5 and X, as defined for formula (I),
or represent groups converted into R 3 , R 4 , R 5 and X, to obtain a compound of formula (Ic)
and thereafter, one or more of the following steps is optionally carried out: (a) when R ′, R ′ 1 is R ′ 5 , Ar ′ and X ′ are other than R, R 1 — R 5 , Ar and X, the conversion of any from R ', R' 1 - R ' 5 , Ar' and X 'in R, R 1 - R 5 , Ar and X to form the compound of formula (I): (b) when R', R ' 1 - R' 5 , Ar 'and X' represent R, R 1 - R 5 , Ar and X, the conversion of any one of R, R 1 - R 5 , Ar and X into another R, R 1 - R 5 , Ar and X with obtaining compounds of formula (I): (c) salt formation and / or solvate of the obtained compound of formula (Ic).
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI94A001099 | 1994-05-27 | ||
IT94MI001099A ITMI941099A1 (en) | 1994-05-27 | 1994-05-27 | KINOLINIC DERIVATIVES |
ITM194A001099 | 1994-05-27 | ||
ITM195A000494 | 1995-03-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU96124804A true RU96124804A (en) | 1999-02-20 |
RU2155754C2 RU2155754C2 (en) | 2000-09-10 |
Family
ID=11369006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU96124804A RU2155754C2 (en) | 1994-05-27 | 1995-05-23 | Quinoline derivatives as techychinin nk3 receptor antagonists |
Country Status (3)
Country | Link |
---|---|
IT (1) | ITMI941099A1 (en) |
RU (1) | RU2155754C2 (en) |
ZA (1) | ZA954269B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
PL1773816T3 (en) | 2004-06-24 | 2015-06-30 | Vertex Pharma | Modulators of ATP-binding cassette transporters |
WO2007079139A2 (en) | 2005-12-28 | 2007-07-12 | Vertex Pharmaceuticals, Inc. | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
JP5645835B2 (en) * | 2008-10-23 | 2014-12-24 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | N- (4- (7-azabicyclo [2.2.1] heptane-7-yl) -2- (trifluoromethyl) phenyl) -4-oxo-5- (trifluoromethyl) -1,4-dihydro Solid form of quinoline-3-carboxamide |
EP2408750B1 (en) | 2009-03-20 | 2015-08-26 | Vertex Pharmaceuticals Incorporated | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
WO2011050220A1 (en) * | 2009-10-23 | 2011-04-28 | Vertex Pharmaceuticals Incorporated | Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide |
CA2865519C (en) | 2012-02-27 | 2018-01-02 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl0-5-hydroxyphenyl-1]-1,4-dihydro-4-oxoquinolone-3-carboxamide for treating cystic fibrosis |
MX370450B (en) | 2014-10-07 | 2019-12-13 | Vertex Pharma | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator. |
-
1994
- 1994-05-27 IT IT94MI001099A patent/ITMI941099A1/en not_active Application Discontinuation
-
1995
- 1995-05-23 RU RU96124804A patent/RU2155754C2/en not_active IP Right Cessation
- 1995-05-25 ZA ZA954269A patent/ZA954269B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1043995B1 (en) | INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS | |
DE69826695T2 (en) | ARYLENE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY OR IMMUNOMODULATORY DISEASES | |
RU2202551C2 (en) | Substituted 3-cyanoquinolines | |
EP1379507B1 (en) | HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS | |
JP2001526223A (en) | Inhibition of p38 kinase using substituted heterocyclic ureas | |
JP2003520272A5 (en) | ||
RU2011129786A (en) | TRIAZOLOPYRIDINES AS PHOSPHODYESTERASE INHIBITORS FOR TREATMENT OF SKIN DISEASES | |
JP2006515604A5 (en) | ||
JPH10500697A (en) | Tachikinin NK (3) Quinoline derivatives as receptor antagonists | |
WO2002012189A1 (en) | Fused bicyclic amide compounds and medicinal use thereof | |
JP2002539128A5 (en) | ||
BRPI0609952A2 (en) | Methods to Modulate Bladder Function | |
RU98110007A (en) | CONDENSED TROPANE DERIVATIVES AS NEURAL MEDIATOR REVERSE INHIBITORS | |
RU96124804A (en) | QUINOLINE DERIVATIVES AS ANTAGONISTS OF NK, TAKHIKININ RECEPTOR | |
JP2004525184A5 (en) | ||
JP2019524844A5 (en) | ||
RU95122587A (en) | 1-PHYLALALCANONS NEW 5-HT * 004 RECEPTOR LIGANDS | |
JP4377454B2 (en) | Salts of quinoline derivatives as NK3 antagonists | |
JP2005500370A5 (en) | ||
RU2005129333A (en) | 4 - [(2,4-Dichloro-5-methoxyphenyl) amino] -6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic damage | |
RU2001111323A (en) | DERIVATIVES 2-PHENILPIRAN-4-SHE | |
RU2155754C2 (en) | Quinoline derivatives as techychinin nk3 receptor antagonists | |
CA2509139A1 (en) | Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
JPH02138214A (en) | Therapeutic method of anxiety | |
JP2007503424A5 (en) |